Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma

BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) have been used to predict therapeutic response in different tumors. However, no assessments of their usefulness have been perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinke, Gari, A., Li, Mei, Chen, Jierong, Qu, Chunhua, Zhang, Lihong, Chen, Jiewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809030/
https://www.ncbi.nlm.nih.gov/pubmed/35109887
http://dx.doi.org/10.1186/s12967-022-03252-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809030/
https://www.ncbi.nlm.nih.gov/pubmed/35109887
http://dx.doi.org/10.1186/s12967-022-03252-7

Ejemplares similares